At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback